Anakinra/cladribine/cyclophosphamideLack of efficacy and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1885卷 / 1期

关键词：

D O I：

10.1007/s40278-021-06810-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：51 / 51

相关论文

共 50 条

[21] SertralineLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1938 (1) : 1156 - 1156
[22] MethylprednisoloneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 275 - 275
[23] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1895 (1) : 165 - 165
[24] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1871 (1) : 52 - 52
[25] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1906 (1) : 166 - 166
[26] ItraconazoleLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1911 (1) : 254 - 254
[27] DenosumabLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1909 (1) : 216 - 216
[28] NifedipineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1918 (1) : 386 - 386
[29] TocilizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1954 (1) : 409 - 409
[30] RituximabLack of efficacy in off-label use: case report
Reactions Weekly, 2023, 1946 (1) : 492 - 492

← 1 2 3 4 5 →